{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:58:23Z","timestamp":1790859503300,"version":"4.1.0"},"reference-count":264,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In recent years, intratumoral microbiota (ITM), a crucial component of the tumor microenvironment, have received increasing attention because of their role in cancer immunotherapy. ITM not only influence tumor initiation and progression but also modulate local and systemic immune responses, thereby affecting the efficacy of immune checkpoint inhibitors and other immunotherapeutic approaches. This review summarizes the compositional characteristics of ITM, their immunoregulatory mechanisms, and their effects on tumor metastasis and responsiveness to immunotherapy. Particular emphasis is placed on interactions between intratumoral microbiota and immune therapies across cancer types, highlighting potential therapeutic strategies that exploit these microbial influences. Furthermore, the review discusses current challenges in integrating intratumoral microbiota into immunotherapeutic paradigms and outlines future research directions. By providing a comprehensive overview of the role of ITM in cancer immunity, this review aims to support advances in precision oncology and foster novel approaches to enhance immunotherapy outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1956198","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:23:33Z","timestamp":1790857413000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Research progress in intratumoral microbiota: unlocking the potential of cancer immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Tian","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Youxian People\u2019s Hospital","place":["Zhuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Youxian People\u2019s Hospital","place":["Zhuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.01.013","article-title":"Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans","volume":"164","author":"Sender","year":"2016","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028316","article-title":"Phylogenetic quantification of intratumor heterogeneity","volume":"8","author":"Watkins","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","article-title":"Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions","volume":"185","author":"Narunsky-Haziza","year":"2022","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3182","article-title":"The human microbiome: at the interface of health and disease","volume":"13","author":"Cho","year":"2012","journal-title":"Nat Rev Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093115","article-title":"Microbes and cancer: friends or faux","volume":"21","author":"Azevedo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-020-00813-8","article-title":"Unexpected guests in the tumor microenvironment: microbiome in cancer","volume":"12","author":"Wong-Rolle","year":"2021","journal-title":"Protein Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.006","article-title":"The fire within: microbes inflame tumors","volume":"157","author":"Gagliani","year":"2014","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.376","article-title":"Intratumor microbiome: selective colonization in the tumor microenvironment and a vital regulator of tumor biology","volume":"4","author":"Jiang","year":"2023","journal-title":"MedComm (2020)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cells13151279","article-title":"Intratumoral microbiome: foe or friend in reshaping the tumor microenvironment landscape","volume":"13","author":"Kyriazi","year":"2024","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38310","article-title":"Tumor microbiota of renal cell carcinoma affects clinical prognosis by influencing the tumor immune microenvironment","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194796","article-title":"Intestinal microbiota: the driving force behind advances in cancer immunotherapy","volume":"14","author":"Dai","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100773","article-title":"Microbiota-derived metabolites: key modulators of cancer immunotherapies","volume":"6","author":"Perl","year":"2025","journal-title":"Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn0704","article-title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer","volume":"7","author":"Mirji","year":"2022","journal-title":"Sci Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-025-01117-x","article-title":"Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer","volume":"32","author":"Wang","year":"2025","journal-title":"J BioMed Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12597","article-title":"Beyond the gut: The intratumoral microbiome's influence on tumorigenesis and treatment response","volume":"44","author":"Zhang","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.ccell.2021.07.002","article-title":"Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy","volume":"39","author":"Shiao","year":"2021","journal-title":"Cancer Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-20-0537","article-title":"A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates Notch and \u03b2-catenin axes","volume":"11","author":"Parida","year":"2021","journal-title":"Cancer Discov"},{"key":"B18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","article-title":"The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer","volume":"34","author":"Wang","year":"2022","journal-title":"Cell Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg5016","article-title":"High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity","volume":"7","author":"Rizvi","year":"2021","journal-title":"Sci Adv"},{"key":"B20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.trecan.2019.12.007","article-title":"The influence of lung microbiota on lung carcinogenesis, immunity, and immunotherapy","volume":"6","author":"Ram\u00edrez-Labrada","year":"2020","journal-title":"Trends Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004698","article-title":"Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature","volume":"10","author":"Wong-Rolle","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2020.1800957","article-title":"Characterization of the human tumor microbiome reveals tumor-type specific intra-cellular bacteria","volume":"9","author":"Livyatan","year":"2020","journal-title":"Oncoimmunology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Ni\u00f1o","year":"2022","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/00220345241262759","article-title":"Salivary microbiome relates to neoadjuvant immunotherapy response in OSCC","volume":"103","author":"Wang","year":"2024","journal-title":"J Dent Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2018.1563410","article-title":"Possible role of Porphyromonas gingivalis in orodigestive cancers","volume":"11","author":"Olsen","year":"2019","journal-title":"J Oral Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00476","article-title":"The oral microbiota may have influence on oral cancer","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.409","article-title":"Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation","volume":"118","author":"Nieminen","year":"2018","journal-title":"Br J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-020-02011-w","article-title":"Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation","volume":"203","author":"Rai","year":"2021","journal-title":"Arch Microbiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgaa062","article-title":"Oral microbial dysbiosis and its performance in predicting oral cancer","volume":"42","author":"Su","year":"2021","journal-title":"Carcinogenesis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/s41598-017-02079-3","article-title":"Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma","volume":"7","author":"Al-Hebshi","year":"2017","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.55","article-title":"HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker","volume":"108","author":"Bussu","year":"2013","journal-title":"Br J Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/odi.12656","article-title":"Epstein-Barr virus in the pathogenesis of oral cancers","volume":"24","author":"Guidry","year":"2018","journal-title":"Oral Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2016\/18593.8229","article-title":"Assesment of correlation of Herpes Simplex Virus-1 with oral cancer and precancer- a comparative study","volume":"10","author":"Jain","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2017.1385369","article-title":"A dysbiotic mycobiome dominated by Candida albicans is identified within oral squamous-cell carcinomas","volume":"9","author":"Perera","year":"2017","journal-title":"J Oral Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13073-017-0405-5","article-title":"Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas","volume":"9","author":"Wang","year":"2017","journal-title":"Genome Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200104123441503","article-title":"Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck","volume":"344","author":"Mork","year":"2001","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.2810","article-title":"Association of intratumoral microbiota with prognosis in patients with nasopharyngeal carcinoma from 2 hospitals in China","volume":"8","author":"Qiao","year":"2022","journal-title":"JAMA Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/newbio244245a0","article-title":"EB viral genomes in epithelial nasopharyngeal carcinoma cells","volume":"244","author":"Wolf","year":"1973","journal-title":"Nat New Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i7.100051","article-title":"Differences in diversity and composition of mucosa-associated colonic microbiota in colorectal cancer and non-colorectal cancer in Indonesia","volume":"31","author":"Darnindro","year":"2025","journal-title":"World J Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12964-024-01771-y","article-title":"IL-1\u03b2 mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer","volume":"22","author":"Zhang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105608","article-title":"Intraneoplastic fungal dysbiosis is associated with colorectal cancer progression and host gene mutation","volume":"113","author":"Yuan","year":"2025","journal-title":"EBioMedicine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.chom.2018.02.004","article-title":"Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells","volume":"23","author":"Chung","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2233-x","article-title":"Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism","volume":"67","author":"Chen","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00020","article-title":"Microbiota disbiosis is associated with colorectal cancer","volume":"6","author":"Gao","year":"2015","journal-title":"Front Microbiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043265","article-title":"Colon cancer microbiome landscaping: differences in right- and left-sided colon cancer and a tumor microbiome-ileal microbiome association","volume":"24","author":"Kneis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317178","article-title":"Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer","volume":"68","author":"Coker","year":"2019","journal-title":"Gut"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah3648","article-title":"Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria","volume":"359","author":"Dejea","year":"2018","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00152-13","article-title":"An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins","volume":"4","author":"Maddocks","year":"2013","journal-title":"mBio"},{"key":"B49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40168-020-00847-4","article-title":"Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer","volume":"8","author":"Xia","year":"2020","journal-title":"Microbiome"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.003","article-title":"Neutrophils restrict tumor-associated microbiota to reduce growth and invasion of colon tumors in mice","volume":"156","author":"Triner","year":"2019","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","article-title":"A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors","volume":"185","author":"Dohlman","year":"2022","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1144021","article-title":"Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis","volume":"13","author":"Thu","year":"2023","journal-title":"Front Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/aem.01235-16","article-title":"The microbiota of breast tissue and its association with breast cancer","volume":"82","author":"Urbaniak","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-021-00874-2","article-title":"Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer","volume":"13","author":"Tzeng","year":"2021","journal-title":"Genome Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083744","article-title":"Microbial dysbiosis is associated with human breast cancer","volume":"9","author":"Xuan","year":"2014","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","article-title":"Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer","volume":"185","author":"Fu","year":"2022","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/srep30751","article-title":"The microbiome of aseptically collected human breast tissue in benign and malignant disease","volume":"6","author":"Hieken","year":"2016","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"14116","DOI":"10.1038\/s41598-020-71102-x","article-title":"Comparative analysis of racial differences in breast tumor microbiome","volume":"10","author":"Thyagarajan","year":"2020","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12885-023-10844-z","article-title":"Fusobacterium nucleatum-derived small extracellular vesicles facilitate tumor growth and metastasis via TLR4 in breast cancer","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010140","article-title":"Low bacterial biomass in human pancreatic cancer and adjacent normal tissue","volume":"26","author":"May","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i19.3038","article-title":"Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients","volume":"12","author":"Nilsson","year":"2006","journal-title":"World J Gastroenterol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s42003-021-02557-5","article-title":"Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer","volume":"4","author":"Guo","year":"2021","journal-title":"Commun Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgaa044","article-title":"Differential flora in the microenvironment of lung tumor and paired adjacent normal tissues","volume":"41","author":"Mao","year":"2020","journal-title":"Carcinogenesis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13059-018-1501-6","article-title":"Interaction between the microbiome and TP53 in human lung cancer","volume":"19","author":"Greathouse","year":"2018","journal-title":"Genome Biol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"12838","DOI":"10.1038\/s41598-019-49195-w","article-title":"Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma","volume":"9","author":"Gomes","year":"2019","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01757","article-title":"PARP1 is up-regulated in non-small cell lung cancer tissues in the presence of the cyanobacterial toxin microcystin","volume":"9","author":"Apopa","year":"2018","journal-title":"Front Microbiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","article-title":"Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions","volume":"102","author":"Lee","year":"2016","journal-title":"Lung Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.531131","article-title":"Microbiome related cytotoxically active CD8+ TIL are inversely associated with lung cancer development","volume":"10","author":"Zheng","year":"2020","journal-title":"Front Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.28","article-title":"IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth","volume":"36","author":"Jungnickel","year":"2017","journal-title":"Oncogene"},{"key":"B73","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1101\/gr.133926.111","article-title":"The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients","volume":"22","author":"Jiang","year":"2012","journal-title":"Genome Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101296","article-title":"Hepatitis C virus improves human Tregs suppressive function and promotes their recruitment to the liver","volume":"8","author":"Ouaguia","year":"2019","journal-title":"Cells"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i36.12781","article-title":"Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment","volume":"20","author":"Testerman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00983-22","article-title":"The intratumoral bacterial metataxonomic signature of hepatocellular carcinoma","volume":"10","author":"Huang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1908","article-title":"Intratumoral microbiome of human primary liver cancer","volume":"6","author":"Qu","year":"2022","journal-title":"Hepatol Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2156255","article-title":"Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma","volume":"15","author":"Chai","year":"2023","journal-title":"Gut Microbes"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1002\/cncr.32403","article-title":"Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China","volume":"125","author":"Shao","year":"2019","journal-title":"Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw078","article-title":"Helicobacter pylori blood biomarker for gastric cancer risk in East Asia","volume":"45","author":"Cai","year":"2016","journal-title":"Int J Epidemiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41419-021-04396-y","article-title":"Interactions between gastric microbiota and metabolites in gastric cancer","volume":"12","author":"Dai","year":"2021","journal-title":"Cell Death Dis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1097\/meg.0000000000000542","article-title":"Bacterial overgrowth and diversification of microbiota in gastric cancer","volume":"28","author":"Wang","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-22-0107","article-title":"Gastric microbiome alterations are associated with decreased CD8+ tissue-resident memory T cells in the tumor microenvironment of gastric cancer","volume":"10","author":"Peng","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1038\/s41598-019-50054-x","article-title":"Association between the relative abundance of gastric microbiota and the risk of gastric cancer: a case-control study","volume":"9","author":"Gunathilake","year":"2019","journal-title":"Sci Rep"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/srep04202","article-title":"Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer","volume":"4","author":"Aviles-Jimenez","year":"2014","journal-title":"Sci Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7150\/thno.65302","article-title":"Mucosal microbiome associates with progression to gastric cancer","volume":"12","author":"Png","year":"2022","journal-title":"Theranostics"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00904-23","article-title":"Bidirectional mediation effects between intratumoral microbiome and host DNA methylation changes contribute to stomach adenocarcinoma","volume":"11","author":"Yue","year":"2023","journal-title":"Microbiol Spectr"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0603-4","article-title":"The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ","volume":"13","author":"Wang","year":"2020","journal-title":"J Ovarian Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193227","article-title":"Gynecological cancer oncobiome systematic review","volume":"17","author":"\u0141atkiewicz","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13073-016-0368-y","article-title":"Potential contribution of the uterine microbiome in the development of endometrial cancer","volume":"8","author":"Walther-Ant\u00f3nio","year":"2016","journal-title":"Genome Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.04.028","article-title":"Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling","volume":"44","author":"Ilhan","year":"2019","journal-title":"EBioMedicine"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021511","article-title":"Microbiome and prostate cancer: a novel target for prevention and treatment","volume":"24","author":"Kustrimovic","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092524","article-title":"Influence of intratumor microbiome on clinical outcome and immune processes in prostate cancer","volume":"12","author":"Ma","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153649","article-title":"The bladder microbiome is associated with epithelial-mesenchymal transition in muscle invasive urothelial bladder carcinoma","volume":"13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04318-2","article-title":"Evidence for an intra-tumoral microbiome in pituitary neuroendocrine tumors with different clinical phenotypes","volume":"163","author":"Ye","year":"2023","journal-title":"J Neuro-Oncol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051261","article-title":"Spatial heterogeneity of intratumoral microbiota: a new frontier in cancer immunotherapy resistance","volume":"13","author":"Tan","year":"2025","journal-title":"Biomedicines"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70273","article-title":"Integrated spatial multi-omics profiling of Fusobacterium nucleatum in breast cancer unveils its role in tumour microenvironment modulation and cancer progression","volume":"15","author":"Zhao","year":"2025","journal-title":"Clin Transl Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.ccell.2023.08.012","article-title":"The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01941-18","article-title":"MicroRNAs of Epstein-Barr virus attenuate T-cell-mediated immune control in vivo","volume":"10","author":"Murer","year":"2019","journal-title":"mBio"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072581","article-title":"An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival","volume":"205","author":"Choy","year":"2008","journal-title":"J Exp Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.03355-13","article-title":"Human papillomavirus type 16 E6* induces oxidative stress and DNA damage","volume":"88","author":"Williams","year":"2014","journal-title":"J Virol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/v5020708","article-title":"Oxidative stress and HPV carcinogenesis","volume":"5","author":"De Marco","year":"2013","journal-title":"Viruses"},{"key":"B105","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","article-title":"Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver","volume":"39","author":"Bertocchi","year":"2021","journal-title":"Cancer Cell"},{"key":"B106","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.1038\/s41598-021-86816-9","article-title":"Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients","volume":"11","author":"Neuzillet","year":"2021","journal-title":"Sci Rep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07182-w","article-title":"A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche","volume":"628","author":"Zepeda-Rivera","year":"2024","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41467-020-16967-2","article-title":"Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression","volume":"11","author":"Parhi","year":"2020","journal-title":"Nat Commun"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.10.005","article-title":"Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours","volume":"43","author":"Wei","year":"2007","journal-title":"Eur J Cancer"},{"key":"B110","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/0-306-46817-4_6","article-title":"Tumor-targeted Salmonella. Highly selective delivery vectors","volume":"465","author":"Bermudes","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.62347\/itso6879","article-title":"Interaction between intratumoral microbiota and neutrophils influences tumor progression","volume":"13","author":"Hu","year":"2024","journal-title":"Am J Clin Exp Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-24-2580","article-title":"Intratumoral Fusobacterium nucleatum recruits tumor-associated neutrophils to promote gastric cancer progression and immune evasion","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.1038\/ncomms9727","article-title":"Gut mucosal microbiome across stages of colorectal carcinogenesis","volume":"6","author":"Nakatsu","year":"2015","journal-title":"Nat Commun"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/biom14080917","article-title":"Intratumoral microbiota: metabolic influences and biomarker potential in gastrointestinal cancer","volume":"14","author":"Bi","year":"2024","journal-title":"Biomolecules"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071942","article-title":"The interaction between gut microbiota and host amino acids metabolism in multiple myeloma","volume":"15","author":"Yang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200470","article-title":"Microbiota in tumors: from understanding to application","volume":"9","author":"Xie","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Sci (New York NY)"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2983-4","article-title":"Highly multiplexed spatial mapping of microbial communities","volume":"588","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.7b02716","article-title":"Rapid sequential in situ multiplexing with DNA exchange imaging in neuronal cells and tissues","volume":"17","author":"Wang","year":"2017","journal-title":"Nano Lett"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03368-8","article-title":"Identification of bacteria-derived HLA-bound peptides in melanoma","volume":"592","author":"Kalaora","year":"2021","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127023","article-title":"Recovering metagenome-assembled genomes from shotgun metagenomic sequencing data: methods, applications, challenges, and opportunities","volume":"260","author":"Zhou","year":"2022","journal-title":"Microbiol Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0029-9","article-title":"Best practices for analysing microbiomes","volume":"16","author":"Knight","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-023-00888-7","article-title":"INVADEseq to identify cell-adherent or invasive bacteria and the associated host transcriptome at single-cell-level resolution","volume":"18","author":"Galeano Ni\u00f1o","year":"2023","journal-title":"Nat Protoc"},{"key":"B124","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40168-018-0485-5","article-title":"The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species","volume":"6","author":"Bilen","year":"2018","journal-title":"Microbiome"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0041-0","article-title":"Culturing the human microbiota and culturomics","volume":"16","author":"Lagier","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-019-0397-0","article-title":"A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip","volume":"3","author":"Jalili-Firoozinezhad","year":"2019","journal-title":"Nat BioMed Eng"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0260-6","article-title":"Targeted isolation and cultivation of uncultivated bacteria by reverse genomics","volume":"37","author":"Cross","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12023","article-title":"Microbial culturomics: paradigm shift in the human gut microbiome study","volume":"18","author":"Lagier","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.cell.2021.02.052","article-title":"Elevated rates of horizontal gene transfer in the industrialized human microbiome","volume":"184","author":"Groussin","year":"2021","journal-title":"Cell"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2018.11.003","article-title":"Contamination in low microbial biomass microbiome studies: issues and recommendations","volume":"27","author":"Eisenhofer","year":"2019","journal-title":"Trends Microbiol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14484","article-title":"The role of the microbiome in cancer and therapy efficacy: focus on lung cancer","volume":"40","author":"Halley","year":"2020","journal-title":"Anticancer Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2008.03.011","article-title":"Redox-based regulation of signal transduction: principles, pitfalls, and promises","volume":"45","author":"Janssen-Heininger","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","article-title":"Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3390\/biom9110735","article-title":"Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"B137","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-019-1008-0","article-title":"The microbiota and microbiome in pancreatic cancer: more influential than expected","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0336-y","article-title":"Inflammatory macrophage dependence on NAD(+) salvage is a consequence of reactive oxygen species-mediated DNA damage","volume":"20","author":"Cameron","year":"2019","journal-title":"Nat Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-010-9225-4","article-title":"Metastasis: cancer cell's escape from oxidative stress","volume":"29","author":"Pani","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-07-0182","article-title":"Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy","volume":"13","author":"Talmadge","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210798","article-title":"High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells","volume":"27","author":"Bottley","year":"2008","journal-title":"Oncogene"},{"key":"B142","doi-asserted-by":"publisher","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6102","article-title":"Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity","volume":"15","author":"Liu","year":"2017","journal-title":"Mol Med Rep"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2019.1581531","article-title":"Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1","volume":"8","author":"Gur","year":"2019","journal-title":"Oncoimmunology"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1553487","article-title":"The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities","volume":"8","author":"Gur","year":"2019","journal-title":"Oncoimmunology"},{"key":"B147","doi-asserted-by":"publisher","first-page":"16189","DOI":"10.1038\/nmicrobiol.2016.189","article-title":"Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs","volume":"2","author":"Javaheri","year":"2016","journal-title":"Nat Microbiol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2011.01.009","article-title":"IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway","volume":"136","author":"Song","year":"2011","journal-title":"Immunol Lett"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-20-4009","article-title":"Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment","volume":"27","author":"Borowsky","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.029","article-title":"Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B","volume":"76","author":"Gao","year":"2022","journal-title":"J Hepatol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","article-title":"Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer","volume":"40","author":"Alam","year":"2022","journal-title":"Cancer Cell"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01068-22","article-title":"Multi-omics integration reveals the crucial role of Fusobacterium in the inflammatory immune microenvironment in head and neck squamous cell carcinoma","volume":"10","author":"Qiao","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"key":"B155","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","article-title":"Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells","volume":"176","author":"Jin","year":"2019","journal-title":"Cell"},{"key":"B156","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejca.2021.03.053","article-title":"Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma","volume":"151","author":"Zhu","year":"2021","journal-title":"Eur J Cancer"},{"key":"B157","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1016\/j.cell.2021.09.019","article-title":"Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment","volume":"184","author":"Lam","year":"2021","journal-title":"Cell"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192282","article-title":"Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling","volume":"217","author":"Shi","year":"2020","journal-title":"J Exp Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-3325","article-title":"Exploiting tertiary lymphoid structures to stimulate antitumor immunity and improve immunotherapy efficacy","volume":"84","author":"Petroni","year":"2024","journal-title":"Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","article-title":"Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer","volume":"54","author":"Overacre-Delgoffe","year":"2021","journal-title":"Immunity"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-2593","article-title":"Intratumoral microbiota composition regulates chemoimmunotherapy response in esophageal squamous cell carcinoma","volume":"83","author":"Wu","year":"2023","journal-title":"Cancer Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","article-title":"Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","article-title":"Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment","volume":"186","author":"Bender","year":"2023","journal-title":"Cell"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.08.090","article-title":"Modulation of pulmonary microbiota by antibiotic or probiotic aerosol therapy: a strategy to promote immunosurveillance against lung metastases","volume":"24","author":"Le Noci","year":"2018","journal-title":"Cell Rep"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00831-6","article-title":"Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice","volume":"6","author":"Lee","year":"2021","journal-title":"Nat Microbiol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.7150\/thno.125301","article-title":"Advances in the engineering of living probiotics for cancer immunotherapy","volume":"16","author":"Muhammad","year":"2026","journal-title":"Theranostics"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128156","article-title":"Unraveling the potential of bioengineered microbiome-based strategies to enhance cancer immunotherapy","volume":"296","author":"Hamza","year":"2025","journal-title":"Microbiol Res"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118559","article-title":"Bacteria-mediated cancer therapy (BMCT): Therapeutic applications, clinical insights, and the microbiome as an emerging hallmark of cancer","volume":"192","author":"Jayaprakash","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.295","article-title":"Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy","volume":"18","author":"Jiang","year":"2010","journal-title":"Mol Ther"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.183","article-title":"Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent","volume":"21","author":"Jiang","year":"2013","journal-title":"Mol Ther"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9537","article-title":"Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin","volume":"9","author":"Zheng","year":"2017","journal-title":"Sci Transl Med"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-025-04197-1","article-title":"Immune-microbiota crosstalk in colorectal cancer: mechanistic pathways, biomarkers, and translational therapeutics","volume":"28","author":"Shekar","year":"2026","journal-title":"Clin Transl Oncol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71575","article-title":"Crosstalk between intratumoral microbes and tumor immunity: Implications for tumor therapy","volume":"15","author":"Li","year":"2026","journal-title":"Cancer Med"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70454","article-title":"Tumor immunotherapy and microbiome: From bench-to-bedside applications","volume":"7","author":"Lin","year":"2026","journal-title":"MedComm (2020)"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c09818","article-title":"Intravenous delivery of living Listeria monocytogenes elicits gasdmermin-dependent tumor pyroptosis and motivates anti-tumor immune response","volume":"16","author":"Liu","year":"2022","journal-title":"ACS Nano"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01694-6","article-title":"Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial","volume":"28","author":"Dizman","year":"2022","journal-title":"Nat Med"},{"key":"B180","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.276","article-title":"The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers","volume":"20","author":"Parato","year":"2012","journal-title":"Mol Ther"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14447","article-title":"Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression","volume":"8","author":"Kalkavan","year":"2017","journal-title":"Nat Commun"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14754","article-title":"Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.7150\/thno.83495","article-title":"OX40L-armed oncolytic virus boosts T-cell response and remodels tumor microenvironment for pancreatic cancer treatment","volume":"13","author":"Liu","year":"2023","journal-title":"Theranostics"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011642","article-title":"Preclinical and clinical evaluation of intratumoral injection of an IL-12 expressing SKV-012 oncolytic virus for advanced solid tumors","volume":"13","author":"Jiang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3848","article-title":"Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity","volume":"21","author":"Ilkow","year":"2015","journal-title":"Nat Med"},{"key":"B188","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41392-022-00921-3","article-title":"Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors","volume":"7","author":"Song","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216041","article-title":"Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressiveness","volume":"555","author":"Bernardo","year":"2023","journal-title":"Cancer Lett"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02335-3","article-title":"Microbiota in cancer: current understandings and future perspectives","volume":"11","author":"Yao","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2785","article-title":"Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer","volume":"5","author":"Pinato","year":"2019","journal-title":"JAMA Oncol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003779","article-title":"Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy","volume":"10","author":"Jing","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.03.002","article-title":"NSCLC immunotherapy efficacy and antibiotic use: A systematic review and meta-analysis","volume":"15","author":"Lurienne","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02234-6","article-title":"A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy","volume":"29","author":"Stein-Thoeringer","year":"2023","journal-title":"Nat Med"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-0455","article-title":"Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer","volume":"82","author":"Chambers","year":"2022","journal-title":"Cancer Res"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c11305","article-title":"Synergistic target of intratumoral microbiome and tumor by metronidazole-fluorouridine nanoparticles","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3390\/nano11020289","article-title":"Targeting the \"Sweet Side\" of tumor with glycan-binding molecules conjugated-nanoparticles: Implications in cancer therapy and diagnosis","volume":"11","author":"Bloise","year":"2021","journal-title":"Nanomaterials (Basel)"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2025.216938","article-title":"Bacteria-assisted metal antitumor immunotherapy","volume":"543","author":"Guo","year":"2025","journal-title":"Coord Chem Rev"},{"key":"B199","doi-asserted-by":"publisher","first-page":"249ra111","DOI":"10.1126\/scitranslmed.3008982","article-title":"Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses","volume":"6","author":"Roberts","year":"2014","journal-title":"Sci Transl Med"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201602722","article-title":"Branched gold nanoparticle coating of Clostridium novyi-NT spores for CT-guided intratumoral injection","volume":"13","author":"Park","year":"2017","journal-title":"Small"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122902","article-title":"Anaerobic bacterial metabolism responsive microspheres for bacterial embolization cancer therapy","volume":"314","author":"Choi","year":"2025","journal-title":"Biomaterials"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.18097\/pbmc20236906409","article-title":"A dual-vector phospholipid nanosystem of doxorubicin: accumulation and cytotoxic effect in breast cancer cells in vitro","volume":"69","author":"Tereshkina","year":"2023","journal-title":"BioMed Khim"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.5c16642","article-title":"Dual targeting biomimetic nanoplatform eradicates oncogenic bacteria while reinvigorating anti-tumor immunity in breast cancer","volume":"17","author":"Yang","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.3c09472","article-title":"Transforming intratumor bacteria into immunopotentiators to reverse cold tumors for enhanced immuno-chemodynamic therapy of triple-negative breast cancer","volume":"145","author":"Liu","year":"2023","journal-title":"J Am Chem Soc"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.123078","article-title":"Ellagic acid-protein nano-complex inhibits tumor growth by reducing the intratumor bacteria and inhibiting histamine production","volume":"317","author":"Wu","year":"2025","journal-title":"Biomaterials"},{"key":"B206","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.actbio.2025.08.059","article-title":"The clinic-in-a-dressing paradigm: Synchronized diagnosis and treatment in chronic wounds via hydrogel-nanofiber matrices","volume":"205","author":"Tang","year":"2025","journal-title":"Acta Biomater"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123100","article-title":"Bioresponsive nanoreactor initiates cascade reactions for tumor vascular normalization and lactate depletion to augment immunotherapy","volume":"317","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn1805","article-title":"In vivo hitchhiking of immune cells by intracellular self-assembly of bacteria-mimetic nanomedicine for targeted therapy of melanoma","volume":"8","author":"Gao","year":"2022","journal-title":"Sci Adv"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101575","article-title":"A macrophage-like biomimetic nanoparticle with high-efficiency biofilm disruption and innate immunity activation for implant-related infection therapy","volume":"31","author":"Wei","year":"2025","journal-title":"Mater Today Bio"},{"key":"B210","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s40820-022-00951-0","article-title":"Bacterial metabolism-initiated nanocatalytic tumor immunotherapy","volume":"14","author":"Wu","year":"2022","journal-title":"Nano Micro Lett"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1039\/d3mh00249g","article-title":"Bacteria engineered with intracellular and extracellular nanomaterials for hierarchical modulation of antitumor immune responses","volume":"10","author":"Song","year":"2023","journal-title":"Mater Horiz"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-026-04110-0","article-title":"A biohybrid platform integrating bacterial propulsion and photoresponsive nanomedicine for adequate intratumoral drug delivery","volume":"24","author":"Yu","year":"2026","journal-title":"J Nanobiotechnology"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102692","article-title":"Genetically engineered bacteria with jacketed biofilm for enhancing drug delivery into tumor","volume":"36","author":"Ma","year":"2026","journal-title":"Mater Today Bio"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.5c01645","article-title":"Engineered bacterial biohybrid-mediated CD47-SIRP\u03b1 blockade and HSP90 inhibition for enhanced immuno-photothermal therapy","volume":"17","author":"Sun","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101144","article-title":"An intratumor bacteria-targeted DNA nanocarrier for multifaceted tumor microenvironment intervention","volume":"27","author":"Wang","year":"2024","journal-title":"Mater Today Bio"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114364","article-title":"Engineered microbial systems for advanced drug delivery","volume":"187","author":"Shen","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.4c00293","article-title":"Engineering cells for cancer therapy","volume":"57","author":"Liu","year":"2024","journal-title":"Acc Chem Res"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189014","article-title":"Role of the intratumoral microbiome in tumor progression and therapeutics implications","volume":"1878","author":"Meng","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16244271","article-title":"Insights into the relationship between the gut microbiome and immune checkpoint inhibitors in solid tumors","volume":"16","author":"Ciernikova","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1575452","article-title":"Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments","volume":"16","author":"Eiman","year":"2025","journal-title":"Front Immunol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14626","article-title":"Gut microbiota shed new light on the management of immune-related adverse events","volume":"13","author":"Tan","year":"2022","journal-title":"Thorac Cancer"},{"key":"B222","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13578-023-01135-y","article-title":"The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies","volume":"13","author":"Guo","year":"2023","journal-title":"Cell Biosci"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101487","article-title":"Microbiome bacterial influencers of host immunity and response to immunotherapy","volume":"5","author":"Yousefi","year":"2024","journal-title":"Cell Rep Med"},{"key":"B224","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41551-021-00807-9","article-title":"Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma","volume":"6","author":"Zheng","year":"2022","journal-title":"Nat BioMed Eng"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.875872","article-title":"AHCC(\u00ae), a standardized extract of cultured Lentinula edodes mycelia, promotes the anti-tumor effect of dual immune checkpoint blockade effect in murine colon cancer","volume":"13","author":"Park","year":"2022","journal-title":"Front Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"B227","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40425-019-0574-4","article-title":"Exploring the emerging role of the microbiome in cancer immunotherapy","volume":"7","author":"Fessler","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax0701","article-title":"Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage","volume":"369","author":"Fluckiger","year":"2020","journal-title":"Science"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1510851","article-title":"Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer","volume":"15","author":"Xu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0882-8","article-title":"Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer","volume":"26","author":"Roberti","year":"2020","journal-title":"Nat Med"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1409464","article-title":"The intratumoral microbiota: a new horizon in cancer immunology","volume":"14","author":"Liu","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-24-3209","article-title":"Mannose enhances immunotherapy efficacy in ovarian cancer by modulating gut microbial metabolites","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.01.009","article-title":"Immune sensing of microbial metabolites: action at the tumor","volume":"55","author":"Frankel","year":"2022","journal-title":"Immunity"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1039\/d1nr04036g","article-title":"Adoptive CD8(+)T-cell grafted with liposomal immunotherapy drugs to counteract the immune suppressive tumor microenvironment and enhance therapy for melanoma","volume":"13","author":"Liu","year":"2021","journal-title":"Nanoscale"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi8075","article-title":"Cell surface-tethered IL-12 repolarizes the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy","volume":"8","author":"Jones","year":"2022","journal-title":"Sci Adv"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05199-8","article-title":"Akkermansia muciniphila: a potential booster to improve the effectiveness of cancer immunotherapy","volume":"149","author":"Fan","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102537","article-title":"Friends close, enemies closer: the complex role of the microbiome in antitumor immunity","volume":"93","author":"Patra","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-023-2634-7","article-title":"The gut microbiome modulate response to immunotherapy in cancer","volume":"68","author":"Jiang","year":"2025","journal-title":"Sci China Life Sci"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1644","article-title":"Probiotics and fecal microbiota transplant for primary and secondary prevention of Clostridium difficile infection","volume":"35","author":"Crow","year":"2015","journal-title":"Pharmacotherapy"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1057492","article-title":"Bibliometric and visual analysis of fecal microbiota transplantation research from 2012 to 2021","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225577","article-title":"Interactions between dietary micronutrients, composition of the microbiome and efficacy of immunotherapy in cancer patients","volume":"14","author":"Fr\u0105k","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.91771","article-title":"Influence of microbiota on tumor immunotherapy","volume":"20","author":"Yu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13817","article-title":"Treatment of early-onset specified and unspecified bipolar disorders: a systematic review and strategies for identifying and managing a thermally dysregulated subtype in children","volume":"152","author":"Papolos","year":"2025","journal-title":"Acta Psychiatr Scand"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2013.832501","article-title":"Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond","volume":"7","author":"Vindigni","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31514","article-title":"Natural polysaccharides regulate intestinal microbiota for inhibiting colorectal cancer","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105523","article-title":"Abundance and metabolism disruptions of intratumoral microbiota by chemical and physical actions unfreeze tumor treatment resistance","volume":"9","author":"Kong","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14864","article-title":"Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma","volume":"32","author":"Voigt","year":"2023","journal-title":"Exp Dermatol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1177\/15347354241269870","article-title":"Targeting the gut microbiome to improve immunotherapy outcomes: a review","volume":"23","author":"David","year":"2024","journal-title":"Integr Cancer Ther"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1155592","article-title":"JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189322","article-title":"Nutritional strategies in oncology: the role of dietary patterns in modulating tumor progression and treatment response","volume":"1880","author":"Wang","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124193","article-title":"Nutrition and diet patterns as key modulators of metabolic reprogramming in melanoma immunotherapy","volume":"14","author":"Grafanaki","year":"2025","journal-title":"J Clin Med"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2022.2133151","article-title":"Diet influences immunotherapy outcomes in cancer patients: a literature review","volume":"75","author":"Kian","year":"2023","journal-title":"Nutr Cancer"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-24-4378","article-title":"Dietary fiber lacks a consistent effect on immune checkpoint blockade efficacy across diverse murine tumor models","volume":"85","author":"Roichman","year":"2025","journal-title":"Cancer Res"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-24-1833","article-title":"Dietary commensal wrestles iron from tumor microenvironment to activate antitumoral macrophages","volume":"84","author":"Lee","year":"2024","journal-title":"Cancer Res"},{"key":"B255","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13167-015-0036-0","article-title":"Probiotics and immunity: provisional role for personalized diets and disease prevention","volume":"6","author":"Bubnov","year":"2015","journal-title":"Epma J"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-025-01588-9","article-title":"The relationship between the gastric cancer microbiome and clinicopathological factors: a metagenomic investigation from the 100,000 genomes project and The Cancer Genome Atlas","volume":"28","author":"Booth","year":"2025","journal-title":"Gastric Cancer"},{"key":"B257","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12866-023-02771-7","article-title":"Dysbiotic microbiome variation in colorectal cancer patients is linked to lifestyles and metabolic diseases","volume":"23","author":"Hoang","year":"2023","journal-title":"BMC Microbiol"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ircmb.2024.12.012","article-title":"Microbiome-mediated immune modulation in tumor microenvironment","volume":"394","author":"Richards","year":"2025","journal-title":"Int Rev Cell Mol Biol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1515\/jtim-2024-0038","article-title":"Intratumoral microbiota in orchestrating cancer immunotherapy response","volume":"12","author":"Zou","year":"2024","journal-title":"J Transl Int Med"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00652-24","article-title":"Cross-laboratory replication of pseudomyxoma peritonei tumor microbiome reveals reproducible microbial signatures","volume":"10","author":"Nieciecki","year":"2025","journal-title":"mSphere"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.73","article-title":"Applying multi-omics toward tumor microbiome research","volume":"2","author":"Zhang","year":"2023","journal-title":"Imeta"},{"key":"B262","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12935-025-03944-2","article-title":"Integration of multi-omics approaches in exploring intra-tumoral heterogeneity","volume":"25","author":"Dong","year":"2025","journal-title":"Cancer Cell Int"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24550","article-title":"In situ imaging for tumor microbiome interactions via imaging mass cytometry on single-cell level","volume":"101","author":"Feng","year":"2022","journal-title":"Cytometry A"},{"key":"B264","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bioactmat.2025.10.012","article-title":"Probiotic-inspired hybrid nanovesicles for enhancing immune checkpoint therapy efficiency via tumor immune microenvironment modulation","volume":"56","author":"Wang","year":"2026","journal-title":"Bioact Mater"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1956198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:23:35Z","timestamp":1790857415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1956198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":264,"alternative-id":["10.3389\/fimmu.2026.1956198"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1956198","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1956198"}}